Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA2431747
Max Phase: Preclinical
Molecular Formula: C30H62N4O6
Molecular Weight: 574.85
Molecule Type: Small molecule
Associated Items:
ID: ALA2431747
Max Phase: Preclinical
Molecular Formula: C30H62N4O6
Molecular Weight: 574.85
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CCCCCCCCCO[C@@H]1[C@@H](N)[C@@H](O[C@H]2[C@H](O)[C@@H](OCCCCCCCCC)[C@H](N)C[C@@H]2N)O[C@H](CN)[C@H]1O
Standard InChI: InChI=1S/C30H62N4O6/c1-3-5-7-9-11-13-15-17-37-27-21(32)19-22(33)28(26(27)36)40-30-24(34)29(25(35)23(20-31)39-30)38-18-16-14-12-10-8-6-4-2/h21-30,35-36H,3-20,31-34H2,1-2H3/t21-,22+,23-,24-,25-,26-,27+,28-,29-,30-/m1/s1
Standard InChI Key: PPBOFDZGLKCMEV-QKOPAVOMSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 574.85 | Molecular Weight (Monoisotopic): 574.4669 | AlogP: 2.43 | #Rotatable Bonds: 21 |
Polar Surface Area: 181.46 | Molecular Species: BASE | HBA: 10 | HBD: 6 |
#RO5 Violations: 2 | HBA (Lipinski): 10 | HBD (Lipinski): 10 | #RO5 Violations (Lipinski): 2 |
CX Acidic pKa: 12.81 | CX Basic pKa: 9.54 | CX LogP: 3.09 | CX LogD: -1.63 |
Aromatic Rings: 0 | Heavy Atoms: 40 | QED Weighted: 0.11 | Np Likeness Score: 1.03 |
1. Zimmermann L, Bussière A, Ouberai M, Baussanne I, Jolivalt C, Mingeot-Leclercq MP, Décout JL.. (2013) Tuning the antibacterial activity of amphiphilic neamine derivatives and comparison to paromamine homologues., 56 (19): [PMID:24083676] [10.1021/jm401148j] |
2. Zimmermann L, Das I, Désiré J, Sautrey G, Barros R S V, El Khoury M, Mingeot-Leclercq MP, Décout JL.. (2016) New Broad-Spectrum Antibacterial Amphiphilic Aminoglycosides Active against Resistant Bacteria: From Neamine Derivatives to Smaller Neosamine Analogues., 59 (20): [PMID:27690420] [10.1021/acs.jmedchem.6b00818] |
3. Zimmermann L, Kempf J, Briée F, Swain J, Mingeot-Leclercq MP, Décout JL.. (2018) Broad-spectrum antibacterial amphiphilic aminoglycosides: A new focus on the structure of the lipophilic groups extends the series of active dialkyl neamines., 157 [PMID:30282323] [10.1016/j.ejmech.2018.08.022] |
Source(1):